These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency. Ratech H, Hirschhorn R, Thorbecke GJ. Am J Pathol; 1985 Apr; 119(1):65-72. PubMed ID: 3872599 [Abstract] [Full Text] [Related]
4. Energy metabolism in adenosine deaminase-inhibited human erythrocytes. Buc HA, Thuillier L, Hamet M, Garreau F, Moncion A, Pérignon JL. Clin Chim Acta; 1986 Apr 15; 156(1):61-9. PubMed ID: 3486057 [Abstract] [Full Text] [Related]
7. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells. Agarwal RP. Biochem Pharmacol; 1980 Feb 15; 29(2):187-93. PubMed ID: 6965857 [No Abstract] [Full Text] [Related]
8. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice. Helland S, Ueland PM. Cancer Res; 1983 Sep 15; 43(9):4142-7. PubMed ID: 6603264 [Abstract] [Full Text] [Related]
11. Animal model for immune dysfunction associated with adenosine deaminase deficiency. Tedde A, Balis ME, Ikehara S, Pahwa R, Good RA, Trotta PP. Proc Natl Acad Sci U S A; 1980 Aug 15; 77(8):4899-903. PubMed ID: 6968908 [Abstract] [Full Text] [Related]
12. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency. Goday A, Simmonds HA, Morris GS, Fairbanks LD. Biochem Pharmacol; 1985 Oct 01; 34(19):3561-9. PubMed ID: 3876835 [Abstract] [Full Text] [Related]
13. Effect of ADA deficiency on cultured murine thymus transplantation. Hong R, Horowitz SD, Fortman C, Martin DW. Clin Immunol Immunopathol; 1982 May 01; 23(2):448-58. PubMed ID: 6980759 [No Abstract] [Full Text] [Related]
14. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo. Svendsen KR, Overgaard-Hansen K, Frederiksen S. Cancer Chemother Pharmacol; 1988 May 01; 21(1):35-9. PubMed ID: 3257721 [Abstract] [Full Text] [Related]
15. Adenosine deaminase from deoxycoformycin-sensitive and -resistant rat hepatoma cells. Purification and characterization. Hunt SW, Hoffee PA. J Biol Chem; 1982 Dec 10; 257(23):14239-44. PubMed ID: 6815190 [Abstract] [Full Text] [Related]
16. Biochemical consequences of adenosine deaminase inhibition in vivo. Differential effects in acute and chronic T cell leukemia. Mitchell BS, Sidi Y, Hershfield M, Koller CA. Ann N Y Acad Sci; 1985 Dec 10; 451():129-37. PubMed ID: 3878114 [No Abstract] [Full Text] [Related]
17. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep. Parks RE, Dawicki DD, Agarwal KC, Chen SF, Stoeckler JD. Ann N Y Acad Sci; 1985 Dec 10; 451():188-203. PubMed ID: 3878117 [No Abstract] [Full Text] [Related]
18. Hypnotic effects of deoxycorformycin in rats. Radulovacki M, Virus RM, Djuricic-Nedelson M, Green RD. Brain Res; 1983 Jul 25; 271(2):392-5. PubMed ID: 6604561 [Abstract] [Full Text] [Related]
19. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes. Gruber HE, Cohen AH, Firestein GS, Redelman D, Bluestein HG. Adv Exp Med Biol; 1986 Jul 25; 195 Pt A():503-7. PubMed ID: 3487921 [No Abstract] [Full Text] [Related]
20. Levels of adenosine deaminase AMP deaminase, and adenylate kinase in cultured human lymphoblast lines: exquisite sensitivity of AMP deaminase to adenosine deaminase inhibitors. Fishbein WN, Davis JI, Winkert JW, Strong DM. Biochem Med; 1981 Dec 25; 26(3):377-86. PubMed ID: 6277304 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]